DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mesna (Mesna) - Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Infection (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mesna where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Methylprednisolone
    Indication: Prophylaxis

Mesna
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Cytarabine
    Indication: Prophylaxis

Rituximab
    Indication: Burkitt's Leukaemia

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Prophylaxis

Mesna
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Lymphoma

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Neupogen; Blood Products; Acyclovir; Antibiotics



Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Prophylaxis

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Mesna
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Mesna
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Leukaemia

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Lymphoma

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Leukaemia

Leucovorin Calcium
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Methotrexate
    Indication: Prophylaxis

Other drugs received by patient: Neupogen; Acyclovir; Antibiotics; Blood Products



Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-05-11

Patient:

Reactions: Hypersensitivity, Petechiae, Off Label Use, Neurotoxicity, Hepatotoxicity, Granulocytopenia, Bone Marrow Failure, White Blood Cell Count Decreased, Gastrointestinal Toxicity, Anaemia, Nephropathy Toxic, Urinary Tract Infection, Toxicity To Various Agents, Soft Tissue Infection, Sepsis, Platelet Count Decreased, Infection

Drug(s) suspected as cause:
Mesna
    Indication: Acute Myeloid Leukaemia

Epirubicin
    Indication: non-Hodgkin's Lymphoma

Epirubicin
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Mesna
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Leucovorin Calcium



Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-05-10

Patient:

Reactions: Hypersensitivity, Neurotoxicity, Off Label Use, Hepatotoxicity, Granulocytopenia, Bone Marrow Failure, White Blood Cell Count Decreased, Gastrointestinal Toxicity, Nephropathy Toxic, Urinary Tract Infection, Anaemia, Soft Tissue Infection, Acute Lymphocytic Leukaemia, Sepsis, Platelet Count Decreased, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Mesna
    Indication: Acute Myeloid Leukaemia

Methotrexate
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Mesna
    Indication: non-Hodgkin's Lymphoma

Vindesine
    Indication: Acute Lymphocytic Leukaemia

Vindesine
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone TAB
    Indication: non-Hodgkin's Lymphoma

Dexamethasone TAB
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Leucovorin Calcium



Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-13

Patient:

Reactions: Stomatitis, Haemoglobin Abnormal, Febrile Neutropenia, Platelet Disorder, Mucosal Inflammation, Diarrhoea, Colitis, Enteritis, Granulocytes Abnormal, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Neuroblastoma

Topotecan
    Dosage: 0.04 mg/kg/day
    Indication: Neuroblastoma

Etoposide
    Dosage: 6.67 mg/kg/day

Vincristine
    Dosage: 0.22 mg/kg/day

Cyclophosphamide
    Dosage: 70 mg/kg/day

Doxorubicin HCL

Cyclophosphamide
    Dosage: 13.3 mg/kg/day

Cyclophosphamide

Etoposide
    Dosage: 6.67 mg/kg/day

Vincristine
    Dosage: 0.22 mg/kg/day
    Indication: Neuroblastoma

Vincristine
    Dosage: 0.22 mg/kg/day

Cyclophosphamide
    Dosage: 70 mg/kg/day

Cyclophosphamide

Topotecan
    Dosage: 0.04 mg/kg/day

Cisplatin
    Dosage: 1.66 mg/kg/day

Mesna
    Dosage: 14 mg/kg/day

Cyclophosphamide
    Dosage: 70 mg/kg/day

Cyclophosphamide

Topotecan
    Dosage: 0.04 mg/kg/day

Cisplatin
    Dosage: 1.66 mg/kg/day

Vincristine
    Dosage: 0.22 mg/kg/day

Vincristine
    Dosage: 0.22 mg/kg/day

Neupogen
    Indication: Neutrophil Count

Cyclophosphamide
    Dosage: 70 mg/kg/day

Topotecan
    Dosage: 0.04 mg/kg/day

Mesna
    Dosage: 14 mg/kg/day

Mesna
    Dosage: 14 mg/kg/day

Mesna
    Dosage: 14 mg/kg/day

Doxorubicin HCL
    Dosage: 0.83 mg/kg/day
    Indication: Neuroblastoma

Doxorubicin HCL

Topotecan
    Dosage: 0.04 mg/kg/day

Cisplatin
    Dosage: 1.66 mg/kg/day
    Indication: Neuroblastoma

Cisplatin
    Dosage: 1.66 mg/kg/day

Etoposide
    Dosage: 6.67 mg/kg/day

Cyclophosphamide
    Dosage: 70 mg/kg/day

Doxorubicin HCL

Cyclophosphamide

Cisplatin

Cisplatin

Etoposide
    Dosage: 6.67 mg/kg/day
    Indication: Neuroblastoma

Etoposide
    Dosage: 6.67 mg/kg/day

Etoposide
    Dosage: 6.67 mg/kg/day

Mesna
    Dosage: 14 mg/kg/day
    Indication: Neuroblastoma

Mesna
    Dosage: 14 mg/kg/day

Vincristine
    Dosage: 0.22 mg/kg/day

Cyclophosphamide
    Dosage: 70 mg/kg/day

Doxorubicin HCL

Doxorubicin HCL

Topotecan
    Dosage: 0.04 mg/kg/day



Possible Mesna side effects in 11 year old male

Reported by a physician from United States on 2012-02-17

Patient: 11 year old male

Reactions: Pyrexia, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 60 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Ifosfamide
    Dosage: 2.8 g/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: 4 mg/kg, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Dosage: 360 mg/m2, unk

Etoposide
    Dosage: unk
    Indication: Sarcoma
    Start date: 2001-10-02

Methotrexate
    Dosage: 12 g/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Filgrastim
    Dosage: 5 mug/kg, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Leucovorin Calcium
    Dosage: 15 mg, unk
    Administration route: Oral
    Indication: Sarcoma
    Start date: 2001-10-02

Doxorubicin HCL
    Dosage: 37.5 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Dexrazoxane Hydrochloride
    Dosage: 375 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Dosage: 560 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: 2 mg/kg, unk



Possible Mesna side effects in

Reported by a individual with unspecified qualification from United States on 2012-02-16

Patient:

Reactions: Confusional State, Psychotic Disorder, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Caecitis, Pericardial Effusion, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Dexrazoxane
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Herceptin
    Dosage: loading dose of 4 mg/kg given on day 1
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Leucovorin Calcium
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Doxorubicin HCL
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Methotrexate
    Dosage: 12 g/m2
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Ifosfamide
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Etoposide
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Mesna
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24



Possible Mesna side effects in 50 year old male

Reported by a physician from Germany on 2012-01-27

Patient: 50 year old male

Reactions: Fatigue, Diarrhoea, Pancytopenia, Hyperhidrosis, Infection

Drug(s) suspected as cause:
Cyclophosphamide

Dexamethasone
    Dosage: 8 mg
    Indication: Evidence Based Treatment

Dacarbazine
    Indication: Thyroid Cancer

Vincristine

Dacarbazine

Cyclophosphamide

Granisetron
    Dosage: 3 mg
    Indication: Evidence Based Treatment

Mesna
    Dosage: 1200 mg

Cyclophosphamide
    Indication: Thyroid Cancer

Vincristine
    Indication: Thyroid Cancer

Vincristine

Dacarbazine



Possible Mesna side effects in male

Reported by a physician from United States on 2011-12-23

Patient: male

Reactions: Vomiting, Pain, Tachycardia, Rhinorrhoea, Pyrexia, Irritability, Candida Test Positive, Neutropenic Infection, Escherichia Test Positive, Diarrhoea, Feeling Hot, Tachypnoea, Septic Shock, Cough, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Indication: Sarcoma
    Start date: 2001-10-02

Cisplatin
    Indication: Sarcoma
    Start date: 2001-10-02

Methotrexate
    Indication: Sarcoma
    Start date: 2001-10-02

Doxorubicin HCL
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: over 90 minutes on day 1, every week for 37 weeks
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna

Filgrastim
    Dosage: then over 15 minutes at hours 8,11,14 post infosamide at 1.8 g/m2 over 4 hours daily for 5 days
    Indication: Sarcoma
    Start date: 2001-10-02

Leucovorin Calcium
    Administration route: Oral
    Indication: Sarcoma
    Start date: 2001-10-02

Etoposide
    Dosage: then over 15 minutes at hours 8,11,14 post infosamide at 1.8 g/m2 over 4 hours daily for 5 days
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: on day 1(loading dose)
    Start date: 2001-10-02

Dexrazoxane Hydrochloride
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Dosage: then over 15 minutes at hours 8,11,14 post infosamide at 1.8 g/m2 over 4 hours daily for 5 days
    Indication: Sarcoma
    Start date: 2001-10-02



Possible Mesna side effects in 11 year old male

Reported by a consumer/non-health professional from United States on 2011-12-22

Patient: 11 year old male

Reactions: Pyrexia, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Indication: Sarcoma
    Start date: 2001-10-02

Doxorubicin HCL
    Indication: Sarcoma
    Start date: 2001-10-02

Leucovorin Calcium
    Administration route: Oral
    Indication: Sarcoma
    Start date: 2001-10-02

Ifosfamide
    Indication: Sarcoma
    Start date: 2001-10-02

Etoposide
    Indication: Sarcoma
    Start date: 2001-10-02

Filgrastim
    Indication: Sarcoma
    Start date: 2011-10-02

Dexrazoxane Hydrochloride
    Indication: Sarcoma
    Start date: 2001-10-02

Methotrexate
    Indication: Sarcoma
    Start date: 2001-10-02



Possible Mesna side effects in 11 year old male

Reported by a physician from United States on 2011-11-29

Patient: 11 year old male

Reactions: Pyrexia, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 2.8 g/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Dosage: 560 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Filgrastim
    Dosage: 5 mug/kg, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Cisplatin
    Dosage: 60 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Dexrazoxane Hydrochloride
    Dosage: 375 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Mesna
    Dosage: 360 mg/m2, unk

Etoposide
    Dosage: unk
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: 4 mg/kg, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Doxorubicin HCL
    Dosage: 37.5 mg/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02

Leucovorin Calcium
    Dosage: 15 mg, unk
    Administration route: Oral
    Indication: Sarcoma
    Start date: 2001-10-02

Trastuzumab
    Dosage: 2 mg/kg, unk

Methotrexate
    Dosage: 12 g/m2, unk
    Indication: Sarcoma
    Start date: 2001-10-02



Possible Mesna side effects in

Reported by a individual with unspecified qualification from United States on 2011-11-21

Patient:

Reactions: Confusional State, Psychotic Disorder, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Caecitis, Pericardial Effusion, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Cisplatin
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Leucovorin Calcium
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Methotrexate
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Herceptin
    Dosage: loading dose of 4 mg/kg given on day 1
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Doxorubicin HCL
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Dexrazoxane Hydrochloride
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Mesna
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24

Etoposide
    Indication: Osteosarcoma Metastatic
    Start date: 2004-09-24



Possible Mesna side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-31

Patient:

Reactions: Toxicity To Various Agents, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin HCL

Cyclophosphamide

Mesna

Eldisine
    Indication: Lymphoma

Eldisine

Eldisine

Bleomycin Sulfate

Methotrexate
    Indication: Lymphoma

Bleomycin Sulfate

Doxorubicin HCL
    Indication: Lymphoma

Eldisine

Bleomycin Sulfate
    Indication: Lymphoma

Cyclophosphamide

Mesna

Prednisone
    Administration route: Oral
    Indication: Lymphoma

Cyclophosphamide
    Indication: Lymphoma

Mesna
    Indication: Lymphoma

Mesna

Bleomycin Sulfate

Doxorubicin HCL

Doxorubicin HCL

Cyclophosphamide

Other drugs received by patient: Neupogen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017